Journal for ImmunoTherapy of Cancer (Nov 2023)

782-D Systemic delivery of novel, allosteric STING agonist CRD3874-SI leads to robust anti-cancer activity by generating pro-inflammatory Type I IFN signals while blocking proton channel mediated toxicity

  • Ciara Kelly,
  • Gaëlle Martin,
  • Fabiane Sônego,
  • Kader Thiam,
  • Angela Pappalardo,
  • Anuj Singh,
  • Monali Banerjee,
  • Sandip Middya,
  • Ritesh Shrivastava,
  • Anindita Middya,
  • Nagaswamy Mane,
  • Nidhi Rawat,
  • Thanilsana Soram,
  • Debjani Chakraborty,
  • Rajib Ghosh,
  • Rubeena Rais Mansuri,
  • Dharmendra Yadav,
  • Anuj Gautam,
  • Kavita Puniya,
  • David Pryde,
  • Sourav Basu,
  • Perrine Martin-Jeantet,
  • Arjun Surya

DOI
https://doi.org/10.1136/jitc-2023-SITC2023.0782-D
Journal volume & issue
Vol. 11, no. Suppl 2

Abstract

Read online

No abstracts available.